Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.3650 (0.32%) ($6.3650 - $6.3650) on Fri. Jan. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.17% (three month average) | RSI | 50 | Latest Price | $6.3650(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.3% a day on average for past five trading days. | Weekly Trend | IOVA advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(39%) IWC(32%) IWO(29%) IWM(27%) IWN(24%) | Factors Impacting IOVA price | IOVA will decline at least -2.585% in a week (0% probabilities). VXX(-9%) UNG(-8%) XLRE(-6%) XBI(-6%) XLV(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.585% (StdDev 5.17%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.32(0.71%) | 10 Day Moving Average | $6.15(3.5%) | 20 Day Moving Average | $6.33(0.55%) | To recent high | -36.6% | To recent low | 13.5% | Market Cap | $932m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |